Cytokinetics, Incorporated2023财年实现净利润-5.26亿美元，同比减少35.22%

自选股智能写手03-03

12月31日，Cytokinetics, Incorporated（CYTK.US）公布财报，公告显示公司2023财年净利润为-5.26亿美元，同比减少35.22%；其中营业收入为7.53百万美元，同比减少92.04%，每股基本收益为-5.45美元。从资产负债表来看，Cytokinetics, Incorporated（CYTK.US）总负债12.11亿美元，其中短期债务27.97百万美元，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2416396460?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-03 00:25","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2416396460","market":"us","top_or_hot":-1,"title":"Cytokinetics, Incorporated2023财年实现净利润-5.26亿美元，同比减少35.22%","media":"自选股智能写手","content":"<div>\n<p>12月31日，Cytokinetics, Incorporated（CYTK.US）公布财报，公告显示公司2023财年净利润为-5.26亿美元，同比减少35.22%；其中营业收入为7.53百万美元，同比减少92.04%，每股基本收益为-5.45美元。从资产负债表来看，Cytokinetics, Incorporated（CYTK.US）总负债12.11亿美元，其中短期债务27.97百万美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300251187dced29&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cytokinetics, Incorporated2023财年实现净利润-5.26亿美元，同比减少35.22%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCytokinetics, Incorporated2023财年实现净利润-5.26亿美元，同比减少35.22%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-03 00:25 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300251187dced29&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>12月31日，Cytokinetics, Incorporated（CYTK.US）公布财报，公告显示公司2023财年净利润为-5.26亿美元，同比减少35.22%；其中营业收入为7.53百万美元，同比减少92.04%，每股基本收益为-5.45美元。从资产负债表来看，Cytokinetics, Incorporated（CYTK.US）总负债12.11亿美元，其中短期债务27.97百万美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300251187dced29&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CYTK","symbol_name":"Cytokinetics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300251187dced29&s=b","article_id":"2416396460","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300251187dced29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2416396460","pubTimestamp":1709396707,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"12月31日，Cytokinetics, Incorporated公布财报，公告显示公司2023财年净利润为-5.26亿美元，同比减少35.22%；其中营业收入为7.53百万美元，同比减少92.04%，每股基本收益为-5.45美元。从资产负债表来看，Cytokinetics, Incorporated总负债12.11亿美元，其中短期债务27.97百万美元，资产负债比为0.69，流动比率为6.10。机构评级：截至2023年12月31日，当前有17家机构对Cytokinetics, Incorporated目标价做出预测，其中目标均价为96.94美元，其中最低目标价为78.00美元，最高目标价为122.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"CYTK":"Cytokinetics"},"translate_title":"Cytokinetics, Incorporated achieved a net profit of-526 million US dollars in fiscal year 2023, a year-on-year decrease of 35.22%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CYTK":1},"content_text":"12月31日，Cytokinetics, Incorporated（CYTK.US）公布财报，公告显示公司2023财年净利润为-5.26亿美元，同比减少35.22%；其中营业收入为7.53百万美元，同比减少92.04%，每股基本收益为-5.45美元。从资产负债表来看，Cytokinetics, Incorporated（CYTK.US）总负债12.11亿美元，其中短期债务27.97百万美元，资产负债比为0.69，流动比率为6.10。机构评级：截至2023年12月31日，当前有17家机构对Cytokinetics, Incorporated目标价做出预测，其中目标均价为96.94美元，其中最低目标价为78.00美元，最高目标价为122.00美元。公司简介：Cytokinetics Inc 是一家生物技术公司，为以肌肉功能下降、肌肉无力和疲劳为特征的疾病开发肌肉生物学驱动的治疗方法。 该公司开发的疗法包括肌萎缩性侧索硬化症、心力衰竭、脊髓性肌萎缩症和慢性阻塞性肺病，这种疗法是基于专门设计的、以增加肌肉功能和收缩力的小分子。该公司正在开发针对肌肉的研究药物，这些药物可能会改善患有毁灭性心血管疾病和肌肉功能受损的神经肌肉疾病患者的健康寿命。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2416396460"}